LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

LLY

747.7

-1.07%↓

JNJ

148.51

-3.47%↓

UNH

310.52

-17.94%↓

ABBV

187.96

-1.03%↓

ABT

129.08

-2.23%↓

Search

LivaNova PLC

Gesloten

44.14 -2.22

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

43.96

Max

45.2

Belangrijke statistieken

By Trading Economics

Inkomsten

-383M

-327M

Verkoop

-4.9M

317M

K/W

Sectorgemiddelde

31.716

56.602

EPS

0.88

Winstmarge

-103.303

Werknemers

2,900

EBITDA

-371M

-286M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+35.51% upside

Dividenden

By Dow Jones

Volgende Winsten

30 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

460M

2.5B

Vorige openingsprijs

46.36

Vorige sluitingsprijs

44.14

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

LivaNova PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mei 2025, 23:20 UTC

Winsten

Aristocrat Leisure Boosts Half-Year Dividend, Keeps Focus on M&A

13 mei 2025, 23:48 UTC

Marktinformatie

Gold Edges Higher, Supported by Signs of Mild U.S. Inflation -- Market Talk

13 mei 2025, 23:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

13 mei 2025, 23:43 UTC

Marktinformatie

Nikkei May Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

13 mei 2025, 23:24 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

13 mei 2025, 23:24 UTC

Marktinformatie
Winsten

Aristocrat's 1H Result Falls Short, Jefferies Says -- Market Talk

13 mei 2025, 22:58 UTC

Winsten

Table: Samsung Fire & Marine 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mei 2025, 22:58 UTC

Winsten

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Net KRW609.03B Vs KRW701.95B

13 mei 2025, 22:58 UTC

Winsten

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Op Pft KRW792.36B Vs Op KRW897.06B

13 mei 2025, 22:58 UTC

Winsten

Samsung Fire & Marine Insurance Co. Ltd. 1Q Consolidated Rev KRW6.106T Vs KRW5.507T

13 mei 2025, 22:38 UTC

Winsten

Aristocrat: Continues to Actively Pursue Strategic M&A Activities

13 mei 2025, 22:38 UTC

Winsten

Aristocrat: Remains Committed to Capital Management Strategy, Ongoing Share Buy-Back Program

13 mei 2025, 22:37 UTC

Winsten

Aristocrat: Expects More Operating Momentum in 2H Amid Product Rollout, Technology Initiatives

13 mei 2025, 22:36 UTC

Winsten

Aristocrat: Sees Accelerating Performance at Interactive Unit Toward FY 2029 US$1 Bln Revenue Target

13 mei 2025, 22:35 UTC

Winsten

Aristocrat: Expects Continued Market Share Gains from Gaming Unit

13 mei 2025, 22:34 UTC

Winsten

Aristocrat: Expects to Deliver NPATA Growth Over the Full Year on a Constant Currency Basis

13 mei 2025, 22:33 UTC

Winsten

Aristocrat: Interactive Business Delivered Strong Revenue Growth

13 mei 2025, 22:33 UTC

Winsten

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

13 mei 2025, 22:33 UTC

Winsten

Aristocrat: Product Madness' Key Social Casino Franchises Continued to Outperform

13 mei 2025, 22:30 UTC

Winsten

Aristocrat Interim Dividend 44 Australian Cents/Share

13 mei 2025, 22:30 UTC

Winsten

Aristocrat 1H Statutory Net Profit from Continuing Operations A$511 Mln, Down 21.6%

13 mei 2025, 22:29 UTC

Winsten

Aristocrat 1H Normalized Operating Revenue A$3 Bln, Up 8.7%

13 mei 2025, 22:28 UTC

Winsten

Aristocrat 1H Normalized Net Profit A$733 Mln, Up 5.6%

13 mei 2025, 21:15 UTC

Winsten

Nu Holdings 1Q Rev $3.2B >NU

13 mei 2025, 21:03 UTC

Top Nieuws

GOP Mega Bill's Details Are Out. Now the Fighting Begins. -- WSJ

13 mei 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

13 mei 2025, 20:32 UTC

Winsten

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mei 2025, 20:31 UTC

Winsten

Alcon 1Q Sales $2.45B >ALC.EB

13 mei 2025, 20:30 UTC

Winsten

Alcon 1Q Rev $2.47B >ALC.EB

13 mei 2025, 20:30 UTC

Winsten

Alcon 1Q EPS 70c >ALC.EB

Peer Vergelijking

Prijswijziging

LivaNova PLC Prognose

Koersdoel

By TipRanks

35.51% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 61.29 USD  35.51%

Hoogste 79 USD

Laagste 55 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor LivaNova PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Technische score

By Trading Central

36.34 / N/ASteun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.